肥胖与非肥胖患者择期腹主动脉瘤修复术后的结局比较
基于血管质量倡议数据库(2003-2017年)比较肥胖与非肥胖患者择期腹主动脉瘤开放修复(OAR)和腔内修复(EVAR)的院内结局。肥胖患者OAR后肾衰竭和伤口感染风险升高,而EVAR后肥胖与主要并发症无关联。需要进一步长期前瞻性研究验证肥胖对腹主动脉瘤修复术后的影响及其临床决策意义。
要点
- 肥胖患者OAR后肾衰竭风险升高(校正OR 1.33,95%CI 1.09-1.63,P=.006),伤口感染风险升高(校正OR 1.75,95%CI 1.11-2.76,P=.02)。
- 肥胖与非肥胖患者OAR和EVAR后死亡率均无显著差异(OAR 2.9% vs 3.2%,P=.50;EVAR 0.5% vs 0.6%,P=.76)。
- EVAR后肥胖与任何主要并发症无关联;肥胖与手术方式在肾衰竭事件中存在显著交互作用(交互OR 1.36,95%CI 1.05-1.75,P=.02)。
核心结论
- 肥胖患者OAR后肾衰竭和伤口感染风险较非肥胖患者升高,而EVAR后肥胖似乎不增加主要不良结局的几率。
研究设计与样本
- 在血管质量倡议数据库中识别2003-2017年所有择期腹主动脉瘤修复患者,肥胖定义为体重指数≥30 kg/m2。
- 共纳入33082例患者,其中OAR组非肥胖4605例(72.4%)、肥胖1754例(27.6%);EVAR组非肥胖18338例(68.6%)、肥胖8385例(31.4%)。
- 采用Student t检验和χ2检验进行单变量分析,采用逻辑回归进行多变量分析,比较肥胖与非肥胖患者的院内死亡率和任何主要并发症(伤口感染、肾衰竭和心肺衰竭)。
主要发现
- OAR和EVAR组肥胖患者均较非肥胖患者年轻(OAR平均年龄67.55[8.26]岁 vs 70.27[8.30]岁;EVAR 71.06[8.22]岁 vs 74.55[8.55]岁;均P<.001)。
- 无论术式,肥胖患者手术时间稍长(OAR 259.02[109.97]分钟 vs 239.37[99.78]分钟;EVAR 138.27[70.64]分钟 vs 134.34[69.98]分钟)且失血量更高(OAR 2030[1823]mL vs 1619[1642]mL;EVAR 228[354]mL vs 207[312]mL;均P<.001)。
- OAR和EVAR组肥胖与非肥胖患者死亡率均无显著差异(OAR 2.9% vs 3.2%,P=.50;EVAR 0.5% vs 0.6%,P=.76)。
- 多变量分析中,OAR组肥胖患者较非肥胖患者肾衰竭几率升高33%(校正OR 1.33,95%CI 1.09-1.63,P=.006),伤口感染几率升高75%(校正OR 1.75,95%CI 1.11-2.76,P=.02)。
- EVAR组肥胖与任何主要并发症无关联;肾衰竭事件中肥胖与手术方式存在显著交互作用,OAR组肥胖患者肾衰竭几率显著高于EVAR组(交互OR 1.36,95%CI 1.05-1.75,P=.02)。
临床怎么用
- 作者在结论中指出,需要进一步长期前瞻性研究验证肥胖对腹主动脉瘤修复术后的影响及这些发现对临床决策的意义。
局限性
- 原文结论指出需要进一步长期前瞻性研究验证肥胖对腹主动脉瘤修复术后的影响及这些发现对临床决策的意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Obesity is a worldwide epidemic, particularly in Western society. It predisposes surgical patients to an increased risk of adverse outcomes. The aim of our study was to use a nationally representative vascular database and to compare in-hospital outcomes in obese vs nonobese patients undergoing elective open aortic repair (OAR) and endovascular aneurysm repair (EVAR). METHODS: All patients undergoing elective abdominal aortic aneurysm repair were identified in the Vascular Quality Initiative database (2003-2017). Obesity was defined as body mass index ≥30 kg/m2. Univariable (Student t-test and χ2 test) and multivariable (logistic regression) analyses were implemented to compare in-hospital mortality and any major complications (wound infection, renal failure, and cardiopulmonary failure) in obese vs nonobese patients. RESULTS: We identified a total of 33,082 patients undergoing elective OAR (nonobese, n = 4605 [72.4%]; obese, n = 1754 [27.6%]) and EVAR (nonobese, n = 18,338 [68.6%]; obese, n = 8385 [31.4%]). Obese patients undergoing OAR and EVAR were relatively younger compared with nonobese patients (mean age [standard deviation], 67.55 [8.26] years vs 70.27 [8.30] years and 71.06 [8.22] years vs 74.55 [8.55] years), respectively; (both P < .001). Regardless of approach, obese patients had slightly longer operative time (OAR, 259.02 [109.97] minutes vs 239.37 [99.78] minutes; EVAR, 138.27 [70.64] minutes vs 134.34 [69.98] minutes) and higher blood loss (OAR, 2030 [1823] mL vs 1619 [1642] mL; EVAR, 228 [354] mL vs 207 [312] mL; both P < .001). There was no significant difference in mortality between the two groups undergoing OAR and EVAR (OAR, 2.9% vs 3.2% [P = .50]; EVAR, 0.5% vs 0.6% [P = .76]). On multivariable analysis, obese patients undergoing OAR had 33% higher odds of renal failure (adjusted odds ratio [OR], 1.33; 95% confidence interval [CI], 1.09-1.63; P = .006) and 75% higher odds of wound infections (adjusted OR, 1.75; 95% CI, 1.11-2.76; P = .02) compared with nonobese patients. However, in patients undergoing EVAR, no association was seen between obesity and any major complications. A significant interaction was found between obesity and surgical approach in the event of renal failure, in which obese patients undergoing OAR had significantly higher odds of renal failure compared with those in the EVAR group (ORinteraction, 1.36; 95% CI, 1.05-1.75; P = .02). CONCLUSIONS: Using a large nationally representative database, we demonstrated an increased risk of renal failure and wound infections in obese patients undergoing OAR compared with nonobese patients. On the other hand, obesity did not seem to increase the odds of major adverse outcomes in patients undergoing EVAR. Further long-term prospective studies are needed to verify the effects of obesity after abdominal aortic aneurysm repair and the implications of these findings in clinical decision-making.
引用
- Locham S, Rizwan M, Dakour-Aridi H, et al. Outcomes after elective abdominal aortic aneurysm repair in obese versus nonobese patients. J Vasc Surg. 2018. PMID: 29887226. doi:10.1016/j.jvs.2018.03.414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。